Principal Financial Group Inc Emergent Bio Solutions Inc. Transaction History

Principal Financial Group Inc

$1.66 Trillion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$1.5 - $3.41 $49,117 - $111,660	-32,745 Reduced 70.34%	13,806 $34,000
Q4 2023 Feb 07, 2024	BUY	$1.82 - $3.16 $13,218 - $22,951	7,263 Added 18.49%	46,551 $111,000
Q3 2023 Nov 02, 2023	SELL	$3.17 - $7.91 $760,898 - $1.9 Million	-240,031 Reduced 85.93%	39,288 $133,000
Q2 2023 Aug 07, 2023	SELL	$7.35 - $13.21 $90,544 - $162,733	-12,319 Reduced 4.22%	279,319 $2.05 Million
Q1 2023 May 09, 2023	SELL	$7.79 - $16.29 $55,994 - $117,092	-7,188 Reduced 2.41%	291,638 $3.02 Million
Q4 2022 Feb 09, 2023	BUY	$11.0 - $21.45 $274,725 - $535,713	24,975 Added 9.12%	298,826 $3.53 Million
Q3 2022 Nov 09, 2022	SELL	$20.09 - $35.8 $48,195 - $85,884	-2,399 Reduced 0.87%	273,851 $5.75 Million
Q2 2022 Aug 10, 2022	SELL	$27.42 - $43.63 $1.09 Million - $1.73 Million	-39,766 Reduced 12.58%	276,250 $8.58 Million
Q1 2022 May 09, 2022	SELL	$36.48 - $52.22 $93,826 - $134,309	-2,572 Reduced 0.81%	316,016 $13 Million
Q4 2021 Feb 09, 2022	BUY	$33.11 - $55.01 $5.06 Million - $8.41 Million	152,961 Added 92.35%	318,588 $13.8 Million
Q3 2021 Nov 09, 2021	BUY	$50.07 - $66.05 $261,565 - $345,045	5,224 Added 3.26%	165,627 $8.29 Million
Q2 2021 Aug 10, 2021	SELL	$56.61 - $80.46 $781,387 - $1.11 Million	-13,803 Reduced 7.92%	160,403 $10.1 Million
Q1 2021 May 10, 2021	BUY	$86.23 - $125.19 $1.81 Million - $2.62 Million	20,962 Added 13.68%	174,206 $16.2 Million
Q4 2020 Feb 08, 2021	BUY	$79.17 - $111.47 $1.26 Million - $1.78 Million	15,958 Added 11.62%	153,244 $13.7 Million
Q3 2020 Nov 06, 2020	SELL	$81.91 - $134.94 $16.7 Million - $27.4 Million	-203,378 Reduced 59.7%	137,286 $14.2 Million
Q2 2020 Aug 05, 2020	SELL	$54.33 - $89.52 $350,265 - $577,135	-6,447 Reduced 1.86%	340,664 $26.9 Million
Q1 2020 May 12, 2020	SELL	$49.34 - $68.76 $683,013 - $951,844	-13,843 Reduced 3.84%	347,111 $20.1 Million
Q4 2019 Feb 05, 2020	BUY	$51.21 - $59.06 $364,871 - $420,802	7,125 Added 2.01%	360,954 $19.5 Million
Q3 2019 Nov 13, 2019	SELL	$40.6 - $57.2 $628,041 - $884,826	-15,469 Reduced 4.19%	353,829 $18.5 Million
Q2 2019 Aug 12, 2019	SELL	$39.92 - $53.86 $657,522 - $887,128	-16,471 Reduced 4.27%	369,298 $17.8 Million
Q1 2019 May 10, 2019	SELL	$48.23 - $66.16 $84,354 - $115,713	-1,749 Reduced 0.45%	385,769 $19.5 Million
Q4 2018 Feb 14, 2019	BUY	$55.63 - $73.24 $216,623 - $285,196	3,894 Added 1.02%	387,518 $23 Million
Q3 2018 Nov 14, 2018	BUY	$52.05 - $66.51 $4.29 Million - $5.48 Million	82,430 Added 27.37%	383,624 $25.3 Million
Q2 2018 Aug 13, 2018	BUY	$48.33 - $55.64 $440,721 - $507,381	9,119 Added 3.12%	301,194 $0
Q1 2018 May 14, 2018	BUY	$44.44 - $54.39 $327,389 - $400,691	7,367 Added 2.59%	292,075 $15.4 Million
Q4 2017 Feb 13, 2018	BUY	$37.77 - $47.75 $747,506 - $945,020	19,791 Added 7.47%	284,708 $13.2 Million
Q3 2017 Nov 02, 2017	BUY	$34.14 - $40.45 $9.04 Million - $10.7 Million	264,917	264,917 $10.7 Million

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$32.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$28.6 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$21 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$18.7 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$16.1 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $420M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account